tetracycline has been researched along with Cardiac-Tamponade* in 6 studies
6 other study(ies) available for tetracycline and Cardiac-Tamponade
Article | Year |
---|---|
Pericardial tamponade and massive pleural effusion complicating orthotopic heart transplantation.
Pericardial and pleural effusions occur commonly after open cardiac procedures. However, the combination of tamponade and massive pleural effusion is not often observed. We present a case of such a patient who received an orthotopic heart transplant in a setting of previously diagnosed systemic sarcoidosis. Treatment ultimately required the creation of a pericardial window and chemical pleurodesis. Topics: Anti-Bacterial Agents; Cardiac Tamponade; Female; Heart Transplantation; Humans; Middle Aged; Pericardial Window Techniques; Pleural Effusion; Pleurodesis; Recurrence; Tetracycline | 1999 |
Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade.
The management of malignant pericardial effusion remains controversial. We present our experience with 93 patients referred for drainage and sclerosing procedures between 1979 and 1994.. With continuous electrocardiographic monitoring, a Kifa catheter was inserted percutaneously into the pericardial sac and allowed to drain. A 100 mg dose of lidocaine hydrochloride was instilled intrapericardially, followed by 500 to 1000 mg tetracycline or doxycycline hydrochloride in 20 to 50 ml normal saline solution. The catheter was clamped for 1 to 2 hours and then reopened, and the procedure was repeated daily until the net drainage was less than 25 ml in 24 hours.. Subjects included 53 women and 40 men (median age 58 years). Eight patients could not undergo sclerosis because of technical failure. Eighty-five patients underwent sclerosis and required a median dose of 1500 mg of the sclerosing agent (range 500 to 700 mg), given in a median of three injections (range one to eight). Complications included pain (17 patients), atrial arrhythmias (eight patients), fever with temperature greater than 38.5 degrees C (seven patients), and infection (one patient). Two patients had cardiac arrest before sclerosis could be attempted. Sixty-eight patients (73%) had the effusion controlled for longer than 30 days, for an overall control rate of 81%. Seven other patients had control of the effusion but died of progressive malignant disease in less than 30 days. The overall median survival was 98 days (range 1 to 1724 days). Comparison of these results with outcomes reported for patients with malignant pericardial effusion who underwent surgical drainage indicates that drainage and sclerosis provide similar survivals but sclerosis carries lower morbidity, mortality, and recurrence rates.. Percutaneous drainage and sclerosis constitutes a safe and effective treatment for malignant pericardial effusion. Surgical management should be reserved for the small percentage of cases that cannot be controlled by this method. Topics: Adult; Aged; Anesthetics, Local; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Breast Neoplasms; Cardiac Tamponade; Catheterization; Doxycycline; Drainage; Electrocardiography, Ambulatory; Female; Fever; Follow-Up Studies; Heart Arrest; Humans; Lidocaine; Lung Neoplasms; Male; Middle Aged; Pain; Pericardial Effusion; Pericardium; Sclerosing Solutions; Survival Rate; Tetracycline; Treatment Outcome | 1996 |
Management of malignant pericardial effusion and tamponade.
Topics: Breast Neoplasms; Cardiac Tamponade; Drainage; Emergencies; Female; Heart Neoplasms; Humans; Lung Neoplasms; Pericardial Effusion; Pericardium; Tetracycline | 1987 |
Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases.
Thirty-three unselected patients with cardiac tamponade secondary to malignant pericardial effusion were treated by intrapericardial instillation of tetracycline hydrochloride. Complete control of the initial signs and symptoms of tamponade was obtained in 30 patients without concomitant chemotherapy or radiotherapy. The procedure did not result in clinically significant complications. Failure of the technique was related to premature removal of the catheter by the patient (one patient) or the inability to totally remove hemorrhagic, clot-filled pericardial fluid (two patients). Survival ranged between 28-704 days and extended survival was related to the performance status and/or chemoradiosensitivity of the primary cancer. No patient successfully treated subsequently developed recurrent cardiac tamponade or alternatively, constrictive pericarditis. Tetracycline pericardial instillation remains a safe, simple, and efficacious treatment of tamponade secondary to malignant disease. Topics: Adult; Aged; Carcinoma, Bronchogenic; Cardiac Tamponade; Electrocardiography; Female; Heart Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Radiography; Sclerosing Solutions; Tetracycline | 1984 |
Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion.
Topics: Aged; Breast Neoplasms; Cardiac Tamponade; Catheterization; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Pericardium; Tetracycline | 1978 |
[Murine typhus revealed by pericarditis].
Topics: Acute Disease; Atrial Fibrillation; Cardiac Tamponade; Cortisone; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Pericardial Effusion; Pericarditis; Pleural Effusion; Rickettsia typhi; Tetracycline; Tuberculosis, Cardiovascular; Typhus, Endemic Flea-Borne | 1972 |